Sumatriptan Tablet
Product Images NDC 63187-164

4 FDA label images from Proficient Rx Lp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 63187-164). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Figure1)

Figure 1 (Figure1)
A line graph showing estimated probability of response over time in minutes from initial dose for placebo and sumatriptan doses of 25 mg, 50 mg, and 100 mg. The graph illustrates response probabilities increasing over 240 minutes, with higher doses showing greater probability of response compared to placebo.*
FDA Label Image

Figure 2 (Figure2)

Figure 2 (Figure2)
A line graph showing the estimated probability of remediation or rescue over 24 hours from the initial dose for placebo and sumatriptan tablets at doses of 25 mg, 50 mg, and 100 mg. The x-axis represents time in hours, and the y-axis shows the probability percentage from 0% to 100%. Four lines correspond to placebo, 25 mg, 50 mg, and 100 mg doses, depicting their respective probability trends over time.*
FDA Label Image

Image 01

Image 01
Label for Sumatriptan 25 mg tablets by Proficient Rx LP, NDC 63187-164-09. Tablets are white to off-white, round, biconvex, uncoated, debossed with "RI61" on one side. Manufactured for Ranbaxy Pharmaceuticals Inc., Jacksonville, FL. Storage recommended at 20°-25°C. The label includes multiple smaller stickers with NDC and batch information.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Sumatriptan, showing its molecular framework including an indole ring, a sulfonamide group, and an associated succinate moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.